Archive — US — techcrunch
Boulevard raises $80M to power self-care boom driven by Botox and GLP-1 surge
Boulevard, a scheduling and payment software provider for the beauty industry, has raised $80 million in Series D funding, enhancing its valuation to $800 million. The growth is attributed to the rise in demand for self-care services, including Botox and GLP-1 medications, particularly through MedSpas. Boulevard serves about 15% of U.S. MedSpas, dramatically increasing its revenue by 500% over three years.
Key points
- Boulevard raised $80 million in Series D funding led by JMI Equity.
- Company valuation increased to $800 million, up from $595 million three years ago.
- Revenue surged over 500% due to rising demand for self-care treatments.
- Boulevard expanded its service to MedSpas, which offer beauty and medical procedures.
- The company adapted its software to meet the needs of MedSpas, achieving HIPAA compliance.
- Boulevard now processes an estimated $5 billion in payments annually.
Why it matters
- The self-care and aesthetic treatment market is growing, fueled by trends such as the popularity of Botox and GLP-1 medications.
- Historically, the beauty industry has seen shifts towards integrating health and wellness services.
- MedSpas represent an emerging sector that blends traditional beauty services with medical treatments.
Boulevard's significant funding and rapid growth underline the booming self-care industry, especially within MedSpas, marking a pivotal evolution in how beauty and medical services intersect.